TGM2 and inflammatory breast carcinoma: In inflammatory breast cancer (IBC), activated T cells could release soluble factors (TNF-α, IL-6, and TGF-β) to facilitate the expression of EMT-related genes, including FN1, VIM, TGM2 and ZEB1, thereby promoting EMT (51).